Literature DB >> 25753472

Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.

Jennifer B Vidler1,2, Kate Gardner1,2, Kenneth Amenyah2, Aleksandar Mijovic2, Swee L Thein1,2.   

Abstract

Delayed haemolytic transfusion reactions (DHTR) are potentially life-threatening complications in patients with sickle cell disease (SCD). Between 1 August 2008 and 31 December 2013, 220 of 637 adult patients in our centre had at least one red blood cell (RBC) transfusion in 2158 separate transfusion episodes. Twenty-three DHTR events occurred in 17 patients (13 female) including 15 HbSS, one HbSC and one HbSβ(0) thalassaemia, equating to a DHTR rate of 7·7% of patients transfused. Mean interval from RBC transfusion to DHTR event was 10·1 ± 5·4 d, and typical presenting features were fever, pain and haemoglobinuria. Twenty of the 23 (87·0%) DHTR episodes occurred following transfusion in the acute setting. Notably, 11/23 (47·8%) of DHTRs were not diagnosed at the time of the event, most were misdiagnosed as a vaso-occlusive crisis. 16/23 DHTRs had 'relative reticulocytopenia', which was more common in older patients. Seven of 23 episodes resulted in alloantibody formation, and three caused autoantibody formation. DHTRs are a severe but uncommon complication of RBC transfusion in SCD and remain poorly recognized, possibly because they mimic an acute painful crisis. Most of the DHTRs are triggered by RBC transfusion in the acute setting when patients are in an inflammatory state.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  acute pain episode; allo-antibodies; delayed haemolytic transfusion reaction; hyperhaemolysis; sickle cell disease

Mesh:

Substances:

Year:  2015        PMID: 25753472     DOI: 10.1111/bjh.13339

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  25 in total

1.  How we evaluate red blood cell compatibility and transfusion support for patients with sickle cell disease undergoing hematopoietic progenitor cell transplantation.

Authors:  Elizabeth S Allen; Randin C Nelson; Willy A Flegel
Journal:  Transfusion       Date:  2018-09-28       Impact factor: 3.157

2.  Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice.

Authors:  Connie M Arthur; Jerry William L Allen; Hans Verkerke; Justin Yoo; Ryan P Jajosky; Kathryn Girard-Pierce; Satheesh Chonat; Patricia Zerra; Cheryl Maier; Jen Rha; Ross Fasano; Cassandra D Josephson; John D Roback; Sean R Stowell
Journal:  Blood Adv       Date:  2021-01-26

Review 3.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

Review 4.  Red cell genotyping precision medicine: a conference summary.

Authors:  Gregory A Denomme; Waseem Q Anani; Neil D Avent; Gregor Bein; Lynne B Briggs; Razvan C Lapadat; Celina Montemayor; Maria Rios; Maryse St-Louis; Lynne Uhl; Silvano Wendel; Willy A Flegel
Journal:  Ther Adv Hematol       Date:  2017-09-13

Review 5.  Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.

Authors:  Eric A Gehrie; Paul M Ness; Evan M Bloch; Seema Kacker; Aaron A R Tobian
Journal:  Transfusion       Date:  2017-06-26       Impact factor: 3.157

Review 6.  How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.

Authors:  France Pirenne; Karina Yazdanbakhsh
Journal:  Blood       Date:  2018-05-03       Impact factor: 22.113

7.  A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data.

Authors:  Ti-Cheng Chang; Kelly M Haupfear; Jing Yu; Evadnie Rampersaud; Vivien A Sheehan; Jonathan M Flanagan; Jane S Hankins; Mitchell J Weiss; Gang Wu; Sunitha Vege; Connie M Westhoff; Stella T Chou; Yan Zheng
Journal:  Blood Adv       Date:  2020-09-22

Review 8.  Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions.

Authors:  Connie M Arthur; Satheesh Chonat; Ross Fasano; Marianne E M Yee; Cassandra D Josephson; John D Roback; Sean R Stowell
Journal:  Transfus Med Rev       Date:  2019-10-18

Review 9.  How I treat the older adult with sickle cell disease.

Authors:  Swee Lay Thein; Jo Howard
Journal:  Blood       Date:  2018-09-11       Impact factor: 22.113

10.  Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.

Authors:  Sarita Coleman; Connie M Westhoff; David F Friedman; Stella T Chou
Journal:  Transfusion       Date:  2019-04-25       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.